Watch CBS News

Diabetes drug shortage due to weight loss trend

In addition to Ozempic, the FDA lists Eli Lilly’s Mounjaro, or tirzepatide, as being in shortage, along with some strengths of the drug Trulicity, or dulaglutide.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.